Finance
Market cap of NeuroSense Therapeutics Ltd [NRSN] reaches 24.88M – now what?
NeuroSense Therapeutics Ltd [NASDAQ: NRSN] gained 5.20% on the last trading session, reaching $1.82 price per share at the time. The company report on February 21, 2024 at 8:30 AM that NeuroSense Reports Additional Positive Results from its ALS Phase 2b PARADIGM Trial. PrimeC demonstrated
